Aemetis, Inc. (NASDAQ:AMTX) Position Raised by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its position in shares of Aemetis, Inc. (NASDAQ:AMTX) by 515.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 120,716 shares of the specialty chemicals company’s stock after purchasing an additional 101,116 shares during the quarter. JPMorgan Chase & Co. owned about 0.24% of Aemetis worth $325,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. Clear Harbor Asset Management LLC acquired a new position in Aemetis during the fourth quarter worth about $44,000. Intech Investment Management LLC bought a new position in shares of Aemetis during the 4th quarter valued at about $46,000. SG Americas Securities LLC acquired a new position in shares of Aemetis in the 4th quarter worth approximately $87,000. Barclays PLC raised its holdings in shares of Aemetis by 274.6% in the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after purchasing an additional 34,816 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Aemetis by 29.6% during the fourth quarter. Bank of New York Mellon Corp now owns 91,880 shares of the specialty chemicals company’s stock valued at $247,000 after purchasing an additional 20,961 shares during the last quarter. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Aemetis Trading Down 0.8 %

Shares of NASDAQ AMTX opened at $1.29 on Friday. Aemetis, Inc. has a one year low of $1.22 and a one year high of $4.73. The business has a 50-day moving average price of $1.65 and a two-hundred day moving average price of $2.45. The firm has a market capitalization of $68.78 million, a PE ratio of -0.57 and a beta of 1.30.

Analysts Set New Price Targets

Several research analysts have issued reports on AMTX shares. Ascendiant Capital Markets upped their price target on Aemetis from $18.00 to $19.00 and gave the company a “buy” rating in a report on Monday, March 17th. StockNews.com raised shares of Aemetis to a “sell” rating in a research note on Wednesday, February 5th. Finally, HC Wainwright reissued a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Friday, March 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $14.56.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.